scispace - formally typeset
F

Francesca Ronchi

Researcher at University of Bern

Publications -  27
Citations -  3297

Francesca Ronchi is an academic researcher from University of Bern. The author has contributed to research in topics: Immune system & Gut flora. The author has an hindex of 18, co-authored 25 publications receiving 2506 citations. Previous affiliations of Francesca Ronchi include University of Lugano.

Papers
More filters
Journal ArticleDOI

Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.

TL;DR: These findings demonstrate that by eliciting different cytokines C. albicans and S. aureus prime TH17 cells that produce either IFN-γ or IL-10, and identify IL-1β and IL-2 as pro- and anti-inflammatory regulators of TH17 Cells both at priming and in the effector phase.
Journal ArticleDOI

Persistent Antigen and Germinal Center B Cells Sustain T Follicular Helper Cell Responses and Phenotype

TL;DR: It is demonstrated that antigen dose determines the size and duration of the Tfh cell response and GC reaction, the transient nature of theTfhcell phenotype is highlighted, and a link between overstimulation of TfH cells and the development of dysregulated humoral immune responses is suggested.
Journal ArticleDOI

The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota

TL;DR: It is shown that the liver forms a second vascular barrier for eliminating commensal bacteria that have escaped from the gut, which may act as a functional vascular firewall that clears commensals that have penetrated either intestinal or systemic vascular circuits.
Journal ArticleDOI

IL-36R ligands are potent regulators of dendritic and T cells

TL;DR: A critical role of IL-36R ligands in the interface between innate and adaptive immunity, leading to the stimulation of T helper responses is indicated.
Journal ArticleDOI

The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.

TL;DR: The status of the knowledge and the open questions in the field focusing on the function of intestinal microbial metabolites or products on CNS cells during healthy and inflammatory conditions, such as multiple sclerosis, Alzheimer's and Parkinson’s diseases, and also neuropsychiatric disorders are discussed.